Literature DB >> 25476559

Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension.

Toshimitsu Tsugu1, Mitsushige Murata2, Takashi Kawakami3, Risako Yasuda3, Hanako Tokuda3, Yugo Minakata3, Yuichi Tamura3, Masaharu Kataoka3, Kentaro Hayashida3, Hikaru Tsuruta3, Yuichiro Maekawa3, Soushin Inoue4, Keiichi Fukuda3.   

Abstract

Balloon pulmonary angioplasty (BPA) may improve hemodynamics and exercise tolerance in patients with chronic thromboembolic pulmonary hypertension (CTEPH). We studied consecutive 25 patients with CTEPH who underwent BPA and evaluated hemodynamics by right-sided heart catheterization. Right ventricular (RV) function was assessed before and after BPA by echocardiography including speckle-tracking echocardiography and 3-dimensional echocardiography. BPA improved the mean pulmonary artery pressure, pulmonary vascular resistance, and cardiac index. BPA also ameliorated the 3-dimentional RV volume, RV ejection fraction, and RV systolic peak strain, all of which were significantly correlated with hemodynamic parameters. The changes in cardiac index were significantly correlated with those in 3-dimentional RV volume index. Furthermore, RV dyssynchrony quantified by the RV strain analyses was ameliorated after BPA even in patients with mild pulmonary hypertension, implicating the merit of BPA in this patient population with CTEPH. BPA not only improved the hemodynamics in patients with CTEPH, but also ameliorated RV remodeling and dyssynchrony as assessed by 3-dimensional echocardiography or speckle-tracking echocardiography. Thus, the assessment of RV function may provide valuable information about the appropriate indication for BPA, its efficacy, and the therapeutic goal for patients with CTEPH.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25476559     DOI: 10.1016/j.amjcard.2014.10.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Update in Pulmonary Vascular Disease 2015.

Authors:  Bradley A Maron; Mark T Gladwin; Marc A Simon
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

2.  The clinical value of assessing right ventricular diastolic function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hidenori Moriyama; Mitsushige Murata; Toshimitsu Tsugu; Takashi Kawakami; Masaharu Kataoka; Takahiro Hiraide; Mai Kimura; Sarasa Isobe; Jin Endo; Takashi Kohno; Yuji Itabashi; Keiichi Fukuda
Journal:  Int J Cardiovasc Imaging       Date:  2017-12-30       Impact factor: 2.357

3.  Residual high intrapulmonary shunt fraction limits exercise capacity in patients treated with balloon pulmonary angioplasty.

Authors:  Makoto Takei; Takashi Kawakami; Masaharu Kataoka; Ichiro Kuwahira; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2018-11-20       Impact factor: 2.037

4.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Marcin Kurzyna; Szymon Darocha; Andrzej Koteja; Radosław Pietura; Adam Torbicki
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-03-06       Impact factor: 1.426

5.  Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension.

Authors:  Mitsushige Murata; Takashi Kawakami; Masaharu Kataoka; Takashi Kohno; Yuji Itabashi; Keiichi Fukuda
Journal:  Pulm Circ       Date:  2017-12-18       Impact factor: 3.017

6.  Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension.

Authors:  Mitsushige Murata; Toshimitsu Tsugu; Takashi Kawakami; Masaharu Kataoka; Yugo Minakata; Jin Endo; Hikaru Tsuruta; Yuji Itabashi; Yuichiro Maekawa; Mitsuru Murata; Keiichi Fukuda
Journal:  Oncotarget       Date:  2016-12-27

7.  Utility of the amplitude of RV1+SV5/6 in assessment of pulmonary hypertension.

Authors:  Sachiyo Igata; Nobuhiro Tahara; Yoichi Sugiyama; Munehisa Bekki; Jun Kumanomido; Atsuko Tahara; Akihiro Honda; Shoko Maeda; Kazutaka Nashiki; Tomohisa Nakamura; Jiahui Sun; Toshi Abe; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

Review 8.  Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Aiko Ogawa; Hiromi Matsubara
Journal:  Front Cardiovasc Med       Date:  2015-02-17

9.  Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressure.

Authors:  Yasuhiro Maruoka; Michinobu Nagao; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Yuzo Yamazaki; Koichiro Abe; Masayuki Sasaki; Kohtaro Abe; Hiroshi Honda
Journal:  Nucl Med Commun       Date:  2017-06       Impact factor: 1.690

10.  Improvement in the electrocardiograms associated with right ventricular hypertrophy after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Authors:  Takahiko Nishiyama; Seiji Takatsuki; Takashi Kawakami; Yoshinori Katsumata; Takehiro Kimura; Masaharu Kataoka; Hikaru Tsuruta; Yuji Itabashi; Mitsushige Murata; Shinsuke Yuasa; Yoshiyasu Aizawa; Keiichi Fukuda
Journal:  Int J Cardiol Heart Vasc       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.